Parkinsonism.
D000380:Agranulocytosis / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009966:Orphenadrine / Q000008:administration & dosage; D010276:Parasympatholytics / Q000008:administration & dosage; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D010301:Parkinson Disease, Postencephalitic; D014839:Vomiting / Q000139:chemically induced
D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D009966:Orphenadrine